Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00738426 · ClinicalTrials.gov registry record · NA

Study of Low Level Laser Therapy for Body Contouring

A NA study of Body Contouring, sponsored by Erchonia Corporation.

Completed
Registry status
NA
Development phase
72
Enrollment target
3
Study locations

NCT00738426: Completed NA study of Body Contouring, sponsored by Erchonia Corporation.

NCT00738426 is a NA study of Body Contouring that has completed, run by Erchonia Corporation. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00738426, a NA study of Body Contouring, has completed, sponsored by Erchonia Corporation.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to determine whether green diode low level laser therapy is effective for body contouring of the waist, hips and thighs.

Conditions Studied

Interventions

  • DEVICE Sham device
  • DEVICE Erchonia ML Scanner (MLS)

Study Locations (3)

Florida

  • Douglas D. Dedo, MD, FACS - Palm Beach Gardens

Indiana

  • Cosmetic Surgery - Marion

Michigan

  • Dr. Gregory C. Roche - Bloomfield Hills

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2007-10
Est. Completion 2008-07
Phase NA
Erchonia Corporation

34 total trials

What the finished NCT00738426 record still lists

NCT00738426 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Body Contouring appearing as the primary indexed condition, and to 2 interventions - of which Sham device is the first listed.

NCT00738426 reports a single indexed study location in Florida, Indiana, Michigan.

Frequently Asked Questions

What is clinical trial NCT00738426 about?

NCT00738426 is a clinical study titled "Study of Low Level Laser Therapy for Body Contouring". The purpose of this study is to determine whether green diode low level laser therapy is effective for body contouring of the waist, hips and thighs.

What is the current status of trial NCT00738426?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2007-10. Estimated completion is 2008-07.

What conditions does trial NCT00738426 study?

This clinical trial studies the following conditions: Body Contouring.

What interventions are being tested in trial NCT00738426?

The interventions under investigation include: Sham device (DEVICE), Erchonia ML Scanner (MLS) (DEVICE).

Who is sponsoring clinical trial NCT00738426?

This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00738426 being conducted?

This trial has 3 study locations across Florida, Indiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Contouring

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00738426's enrollment target sits among peer trials

72 1089th of 2000 higher than 899 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00738426, the US trial registry maintained by the National Library of Medicine. NCT00738426 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.